LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,102,000 | -13.5% | 12,500,000 | 0.0% | 0.01% | -27.3% |
| Q1 2020 | $5,898,000 | -36.4% | 12,500,000 | 0.0% | 0.01% | -15.4% |
| Q4 2019 | $9,271,000 | +13.2% | 12,500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $8,193,000 | -39.0% | 12,500,000 | 0.0% | 0.01% | -40.9% |
| Q2 2019 | $13,435,000 | +33.0% | 12,500,000 | +25.0% | 0.02% | +29.4% |
| Q1 2019 | $10,105,000 | -28.0% | 10,000,000 | -20.0% | 0.02% | -34.6% |
| Q4 2018 | $14,026,000 | -25.0% | 12,500,000 | 0.0% | 0.03% | -13.3% |
| Q3 2018 | $18,699,000 | -7.3% | 12,500,000 | 0.0% | 0.03% | -14.3% |
| Q2 2018 | $20,162,000 | +24.1% | 12,500,000 | 0.0% | 0.04% | +25.0% |
| Q1 2018 | $16,246,000 | -8.3% | 12,500,000 | 0.0% | 0.03% | -6.7% |
| Q4 2017 | $17,710,000 | -12.8% | 12,500,000 | 0.0% | 0.03% | -18.9% |
| Q3 2017 | $20,312,000 | -21.8% | 12,500,000 | 0.0% | 0.04% | -24.5% |
| Q2 2017 | $25,984,000 | +12.0% | 12,500,000 | 0.0% | 0.05% | +11.4% |
| Q1 2017 | $23,195,000 | +34.9% | 12,500,000 | +30.6% | 0.04% | +25.7% |
| Q4 2016 | $17,190,000 | -20.6% | 9,570,000 | 0.0% | 0.04% | -18.6% |
| Q3 2016 | $21,640,000 | +27.6% | 9,570,000 | +6.3% | 0.04% | +19.4% |
| Q2 2016 | $16,965,000 | +26.9% | 9,000,000 | +9.1% | 0.04% | +24.1% |
| Q1 2016 | $13,365,000 | -10.1% | 8,250,000 | -2.9% | 0.03% | -14.7% |
| Q4 2015 | $14,864,000 | – | 8,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 5,250,000 | $4,410,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $5,475,000 | 0.04% |
| MACKAY SHIELDS LLC | 30,000 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 320,000 | $252,000 | 0.00% |